BPOM Issues Emergency Use Authorization for Moderna Vaccine

2 July 2021 13:02 WIB

TEMPO.CO, JakartaThe Food and Drug Monitoring Agency (BPOM) has issued an emergency use authorization (EUA) for the Covid-19 vaccine produced by the United States, Moderna.

“We added one more vaccine brand that has received EUA from the BPOM, namely the Moderna vaccine,” said the BPOM Head Penny Lukito in a press conference on Friday, July 2, 2021.

Penny said Moderna was the first vaccine with an mRNA platform that was granted an emergency use authorization by BPOM. This vaccine brand would enter Indonesia through the COVAX scheme.

Based on the results of phase III clinical trials, Penny said the vaccine efficacy showed 94.1 percent in the 18-65 year age group and 86.4 percent in people aged 65 and over.

This vaccine was also said to provide a similar safety and efficacy profile in comorbid groups. Penny said the U.S.-made vaccine could be given to individuals with chronic lung disease, heart disease, severe obesity, diabetes, liver disease, and HIV.

“The POM Agency appreciates the expert team of the national committee for the Covid-19 vaccine assessment and ITAGI who have jointly conducted an intensive study so that the Moderna vaccine EUA can be issued in response to the high vaccine need,” Penny added.

Besides Moderna, BPOM has previously provided EUA for four other vaccine brands, namely CoronaVac produced by Sinovac China, Sinovac vaccine developed by Bio Farma, AstraZeneca, and Sinopharm.

Read: Indonesia to Receive Moderna Vaccine Donation from U.S.

FRISKI RIANA

 



BPOM Assures All Domestically Made COVID Vaccines are Halal

7 hari lalu

BPOM Assures All Domestically Made COVID Vaccines are Halal

BPOM has confirmed that all three domestic manufacturers of COVID-19 vaccines have obtained halal certificates from the concerned authority.


Indonesia's Latest Flying Rule Mandates Passengers to Have Booster Shots

16 hari lalu

Indonesia's Latest Flying Rule Mandates Passengers to Have Booster Shots

The requirement for air passengers to have received a booster shot will be applied in September.


BPOM Comments on Singapore Recalling ABC Sauce Products

27 hari lalu

BPOM Comments on Singapore Recalling ABC Sauce Products

The BPOM commented on Singapore's food agency or SFA which recalled two ABC sauce products.


Erick Thohir Claims Domestic Vaccine Indovac Has High Efficacy, Halal

33 hari lalu

Erick Thohir Claims Domestic Vaccine Indovac Has High Efficacy, Halal

SOE Minister Erick Thohir disclosed that based on the clinical trial, homegrown COVID-19 vaccine developed by Bio Farma, Indovac, has high efficacy.


Booster Jab Required for Long-distance Train Travelers Starting August 30

38 hari lalu

Booster Jab Required for Long-distance Train Travelers Starting August 30

Passengers of long-distance trains aged 18 years and above are required to get a booster shot starting Tuesday, August 30.


Australia Researchers Strive for "Universal" Vaccine for All COVID-19 Variants

47 hari lalu

Australia Researchers Strive for "Universal" Vaccine for All COVID-19 Variants

Australian medical researchers are working towards creating a booster vaccine capable of dealing with the ever-growing array of COVID-19 variants.


Covid-19 Vaccine Fourth Dose Rollout After Third Dose Coverage Touches 50%: Health Ministry

2 Agustus 2022

Covid-19 Vaccine Fourth Dose Rollout After Third Dose Coverage Touches 50%: Health Ministry

Health Ministry said that the fourth dose of Covid-19 vaccine will be provided to the general public once the coverage of the third dose reaches 50%


Indonesia Producing mRNA COVID-19 Vaccine with China's Technology

28 Juli 2022

Indonesia Producing mRNA COVID-19 Vaccine with China's Technology

Indonesia is set to produce a COVID-19 vaccine using messenger RNA (mRNA) technology, which is similar to Pfizer and Moderna.


Health Ministry Discusses Second Booster Dose of COVID-19 Vaccine

22 Juli 2022

Health Ministry Discusses Second Booster Dose of COVID-19 Vaccine

Health Ministry is discussing the distribution of the second booster dose of the COVID-19 vaccine.


Indonesia Allows Emergency Use of Paxlovid; Reportedly 90% Effective as Covid-19 Drug

19 Juli 2022

Indonesia Allows Emergency Use of Paxlovid; Reportedly 90% Effective as Covid-19 Drug

Paxlovid is produced by Pfizer as a drug claimed to have up to 90 percent effectiveness in preventing severe COVID-19 symptoms.